Biodesix Inc (BDSX) shareholders
BDSXNasdaqServices-Medical LaboratoriesFiscal year ends December 31
$9.88+0.09 (+0.92%)
Close on Nov 13, 2026Market cap $104.25MP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
41.4%
4M of 11M shares
Institutional holders
45
10 new, 5 sold out
Net institutional buying
0M
In Q2 2026
Insider trades, 12 months
7 buys · 15 sales
Net bought $4.00M
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Lawrence T. Kennedy, Jr. Joint filing with Lawrence T. Kennedy, Jr. Perpetuity Trust UAD 6/30/16 (8.50%), Lawrence T. Kennedy, Jr. Revocable Trust UAD 6/19/01 (7.10%) | 25,622,151 | 17.60% | 13D (active) amendment | May 21, 2024 |
| Perceptive Credit Advisors LLC Joint filing with Perceptive Advisors LLC (5.10%), Joseph Edelman (5.10%) | 7,673,880 | 5.10% | 13G (passive) | May 12, 2025 |
| John Patience | 7,659,411 | 6.70% | 13D (active) amendment | Apr 5, 2024 |
| Schuler Jack W Joint filing with Jack W. Schuler Living Trust (16.10%), Jack W. Schuler 2025 GRAT (7.70%) | 2,333,945 | 24.00% | 13D (active) amendment | Jan 23, 2026 |
| Orin Hirschman Joint filing with AIGH Capital Management LLC (7.70%) | 758,328 | 7.70% | 13G (passive) | Mar 31, 2026 |
| Guy Levy Joint filing with Soleus Capital Master Fund, L.P. (5.10%), Soleus Capital, LLC (5.10%) and 3 more | 525,241 | 5.10% | 13G (passive) | Jun 17, 2026 |
| Soleus Capital Management, L.P. Joint filing with Soleus Capital Master Fund, L.P. (6.30%), Soleus Capital, LLC (6.30%) and 3 more | 500,000 | 6.30% | 13G (passive) | Jan 12, 2026 |
| Telemark Fund, LP Joint filing with Telemark Asset Management, LLC (5.40%), Colin S. McNay (5.40%) | 427,824 | 5.40% | 13G (passive) | Jan 22, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of BDSX | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| AIGH Capital Management LLC | 678,328 | 6.43% | $15.30M | −80,000 | 0.96% |
| Soleus Capital Management, L.P. | 585,958 | 5.55% | $13.21M | +169,359 | 0.46% |
| Telemark Asset Management, LLC | 489,824 | 4.64% | $11.05M | – | 0.80% |
| abrdn plc | 388,639 | 3.68% | $8.76M | −69,799 | 0.01% |
| Birchview Capital, LP | 286,804 | 2.72% | $6.47M | – | 3.02% |
| Vanguard Capital Management LLC | 284,169 | 2.69% | $6.41M | +29,008 | 0.00% |
| Essex Investment Management Co LLC | 241,915 | 2.29% | $5.46M | +109,829 | 0.71% |
| Opaleye Management Inc. | 180,000 | 1.71% | $4.06M | −58,047 | 0.37% |
| Marshall Wace, Llp | 116,199 | 1.10% | $2.62M | −25,437 | 0.00% |
| Perceptive Advisors LLC | 108,694 | 1.03% | $2.45M | New | 0.04% |
| Jane Street Group, LLC | 91,506 | 0.87% | $2.06M | +64,475 | 0.00% |
| Two Sigma Investments, LP | 86,824 | 0.82% | $1.96M | +41,593 | 0.00% |
| Legato Capital Management LLC | 81,381 | 0.77% | $1.84M | +40,207 | 0.15% |
| Walleye Capital LLC | 74,447 | 0.71% | $1.68M | +63,607 | 0.01% |
| Stempoint Capital LP | 70,000 | 0.66% | $1.58M | −70,008 | 0.27% |
| Geode Capital Management, LLC | 67,657 | 0.64% | $1.53M | +17,659 | 0.00% |
| Trexquant Investment LP | 57,972 | 0.55% | $1.31M | −11,629 | 0.01% |
| Gsa Capital Partners Llp | 46,989 | 0.45% | $1.06M | +7,583 | 0.07% |
| Perkins Capital Management Inc | 44,618 | 0.42% | $1.01M | −165 | 0.76% |
| BlackRock, Inc. | 43,026 | 0.41% | $970.24K | +18,560 | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 45 | 4M | 41.4% | 10 / 15 | 13 / 5 | 1M | 0M |
| Q1 2026 | 40 | 4M | 37.6% | 24 / 6 | 2 / 9 | 3M | 0M |
| Q4 2025 | 26 | 2M | 15.4% | 7 / 7 | 5 / 7 | 0M | 0M |
| Q3 2025 | 26 | 1M | 13.6% | 5 / 5 | 14 / 20 | 0M | 0M |
| Q2 2025 | 41 | 2M | 16.9% | 6 / 7 | 12 / 25 | 0M | 1M |
| Q1 2025 | 60 | 3M | 25.3% | 11 / 13 | 20 / 10 | 0M | 1M |
| Q4 2024 | 59 | 3M | 30.5% | 18 / 21 | 6 / 10 | 0M | 1M |
| Q3 2024 | 52 | 3M | 32.2% | 13 / 13 | 6 / 5 | 1M | 0M |
| Q2 2024 | 46 | 3M | 28.0% | 18 / 14 | 8 / 14 | 2M | 0M |
| Q1 2024 | 42 | 1M | 10.1% | 11 / 15 | 8 / 6 | 0M | 0M |
| Q4 2023 | 38 | 1M | 10.6% | 5 / 14 | 10 / 3 | 0M | 0M |
| Q3 2023 | 37 | 1M | 10.6% | 11 / 6 | 12 / 3 | 0M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
16 funds held BDSX in Q2 2026, 74% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of BDSX | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 204,100 | 1.93% | $4.60M | 0.00% | Jun 30, 2026 |
| Vanguard Extended Market Index Fund | 72,031 | 0.68% | $1.62M | 0.00% | Jun 30, 2026 |
| 1290 Essex Small Cap Growth Fund | 58,950 | 0.56% | $1.25M | 1.08% | Jul 31, 2026 |
| Fidelity Extended Market Index Fund | 21,069 | 0.20% | $343.85K | 0.00% | May 31, 2026 |
| iShares Micro-Cap ETF | 17,404 | 0.16% | $392.46K | 0.03% | Jun 30, 2026 |
| Ultra-Small Company Fund | 15,000 | 0.14% | $338.25K | 0.34% | Jun 30, 2026 |
| Ultra-Small Company Market Fund | 10,000 | 0.09% | $225.50K | 0.15% | Jun 30, 2026 |
| Fidelity Total Market Index Fund | 6,664 | 0.06% | $108.76K | 0.00% | May 31, 2026 |
| Fidelity Series Total Market Index Fund | 6,004 | 0.06% | $97.99K | 0.00% | May 31, 2026 |
| Fidelity Nasdaq Composite Index Fund | 5,483 | 0.05% | $89.48K | 0.00% | May 31, 2026 |
| Vanguard Institutional Total Stock Market Index Fund | 4,505 | 0.04% | $101.59K | 0.00% | Jun 30, 2026 |
| Vanguard Balanced Index Fund | 3,533 | 0.03% | $79.67K | 0.00% | Jun 30, 2026 |
| 1290 VT Micro Cap Portfolio | 1,156 | 0.01% | $26.07K | 0.01% | Jun 30, 2026 |
| Victory Extended Market Index Fund | 537 | 0.01% | $11.38K | 0.00% | Jul 31, 2026 |
| Corgi Genomics & Precision Medicine ETF | 462 | 0.00% | $10.42K | 0.61% | Jun 30, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Scott Hutton | President & CEO, Director | 48,767 | 0.46% | Feb 23, 2026 |
| Chris Vazquez | Chief Accounting Officer | 1,586 | 0.02% | Feb 23, 2026 |
| Gary Anthony Pestano | Chief Development Officer | 10,359 | 0.10% | Feb 23, 2026 |
| Robin Harper Cowie | CFO, Sec'y & Treasurer | 16,231 | 0.15% | Feb 23, 2026 |
| Kieran O'Kane | Chief Commercial Officer | 9,819 | 0.09% | Feb 23, 2026 |
| John Patience | Director | 378,536 | 3.59% | Oct 2, 2026 |
| Lawrence T. Kennedy Jr | Director, 10% owner | 25,454,283 | 241.25% | Jan 6, 2026 |
| Matthew Strobeck | Director | 5,518,151 | 52.30% | Jan 6, 2026 |
| Jon Faiz Kayyem | Director | 357,537 | 3.39% | Jan 6, 2026 |
| Hany Massarany | Director | 363,499 | 3.45% | Jan 6, 2026 |
| Jean M. Franchi | Director | 108,140 | 1.02% | Jan 6, 2026 |
| Charles M. Watts | Director | 421,705 | 4.00% | Apr 2, 2025 |
| Jack W. Schuler | 10% owner | 2,455,810 | 23.28% | Nov 12, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Jack W. Schuler 10% owner | Nov 10, 2026 | Buy | +100,000 | $10.02 | $1.00M | 655,810 |
| John Patience Director | Sep 30, 2026 | Option exercise | +1,360 | – | – | 26,743 |
| Jack W. Schuler 10% owner | Aug 12, 2026 | Buy | +15,000 | $24.47 | $367.05K | 555,810 |
| Jack W. Schuler 10% owner | Aug 11, 2026 | Buy | +13,700 | $24.01 | $328.94K | 540,810 |
| Jack W. Schuler 10% owner | Aug 10, 2026 | Buy | +13,900 | $24.25 | $337.08K | 527,110 |
| John Patience Director | Jun 30, 2026 | Option exercise | +1,361 | – | – | 25,383 |
| John Patience Director | Mar 31, 2026 | Option exercise | +1,361 | – | – | 24,022 |
| Chris Vazquez Chief Accounting Officer | Feb 23, 2026 | Sale | −211 | $12.78 | $2.70K | 1,586 |
| Scott Hutton President & CEO, Director | Feb 23, 2026 | Sale | −1,490 | $12.78 | $19.04K | 48,767 |
| Kieran O'Kane Chief Commercial Officer | Feb 23, 2026 | Sale | −535 | $12.78 | $6.84K | 9,819 |
| Gary Anthony Pestano Chief Development Officer | Feb 23, 2026 | Sale | −556 | $12.78 | $7.11K | 10,359 |
| Robin Harper Cowie CFO, Sec'y & Treasurer | Feb 23, 2026 | Sale | −535 | $12.78 | $6.84K | 16,231 |
| Chris Vazquez Chief Accounting Officer | Feb 20, 2026 | Option exercise | +563 | – | – | 1,797 |
| Scott Hutton President & CEO, Director | Feb 20, 2026 | Option exercise | +4,844 | – | – | 50,257 |
| Kieran O'Kane Chief Commercial Officer | Feb 20, 2026 | Option exercise | +1,469 | – | – | 10,354 |
| Gary Anthony Pestano Chief Development Officer | Feb 20, 2026 | Option exercise | +1,528 | – | – | 10,915 |
| Robin Harper Cowie CFO, Sec'y & Treasurer | Feb 20, 2026 | Option exercise | +1,469 | – | – | 16,766 |
| Kieran O'Kane Chief Commercial Officer | Feb 10, 2026 | Sale | −584 | $10.08 | $5.89K | 8,885 |
| Scott Hutton President & CEO, Director | Feb 10, 2026 | Sale | −3,559 | $10.08 | $35.87K | 45,413 |
| Robin Harper Cowie CFO, Sec'y & Treasurer | Feb 10, 2026 | Sale | −941 | $10.08 | $9.49K | 15,297 |
| Chris Vazquez Chief Accounting Officer | Feb 10, 2026 | Sale | −101 | $10.08 | $1.02K | 1,234 |
| Gary Anthony Pestano Chief Development Officer | Feb 10, 2026 | Sale | −540 | $10.08 | $5.44K | 9,387 |
| Kieran O'Kane Chief Commercial Officer | Feb 9, 2026 | Option exercise | +1,600 | – | – | 9,469 |
| Scott Hutton President & CEO, Director | Feb 9, 2026 | Option exercise | +9,998 | – | – | 48,972 |
| Robin Harper Cowie CFO, Sec'y & Treasurer | Feb 9, 2026 | Option exercise | +2,584 | – | – | 16,238 |
| Chris Vazquez Chief Accounting Officer | Feb 9, 2026 | Option exercise | +263 | – | – | 1,335 |
| Gary Anthony Pestano Chief Development Officer | Feb 9, 2026 | Option exercise | +1,481 | – | – | 9,927 |
| Jack W. Schuler 10% owner | Jan 26, 2026 | Buy | +20,000 | $11.80 | $236.00K | 1,563,210 |
| Jack W. Schuler 10% owner | Jan 23, 2026 | Buy | +80,000 | $11.81 | $944.80K | 1,543,210 |
| Jack W. Schuler 10% owner | Jan 22, 2026 | Buy | +82,465 | $10.96 | $903.82K | 1,463,210 |
| Gary Anthony Pestano Chief Development Officer | Jan 16, 2026 | Sale | −298 | $8.15 | $2.43K | 8,446 |
| Kieran O'Kane Chief Commercial Officer | Jan 16, 2026 | Sale | −298 | $8.15 | $2.43K | 7,869 |
| Scott Hutton President & CEO, Director | Jan 16, 2026 | Sale | −970 | $8.15 | $7.91K | 38,974 |
| Chris Vazquez Chief Accounting Officer | Jan 16, 2026 | Sale | −83 | $8.15 | $676 | 1,072 |
| Robin Harper Cowie CFO, Sec'y & Treasurer | Jan 16, 2026 | Sale | −298 | $8.15 | $2.43K | 13,654 |
| Gary Anthony Pestano Chief Development Officer | Jan 15, 2026 | Option exercise | +805 | – | – | 8,744 |
| Kieran O'Kane Chief Commercial Officer | Jan 15, 2026 | Option exercise | +805 | – | – | 8,167 |
| Scott Hutton President & CEO, Director | Jan 15, 2026 | Option exercise | +2,633 | – | – | 39,944 |
| Chris Vazquez Chief Accounting Officer | Jan 15, 2026 | Option exercise | +219 | – | – | 1,155 |
| Robin Harper Cowie CFO, Sec'y & Treasurer | Jan 15, 2026 | Option exercise | +805 | – | – | 13,952 |
| John Patience Director | Jan 5, 2026 | Option exercise | +1,143 | – | – | 22,661 |
| Kieran O'Kane Chief Commercial Officer | Nov 10, 2025 | Sale | −25 | $7.62 | $191 | 7,362 |
| Kieran O'Kane Chief Commercial Officer | Nov 10, 2025 | Option exercise | +75 | – | – | 7,387 |
| Scott Hutton President & CEO, Director | Nov 10, 2025 | Sale | −189 | $7.62 | $1.44K | 37,311 |
| Scott Hutton President & CEO, Director | Nov 10, 2025 | Option exercise | +611 | – | – | 37,500 |
| Chris Vazquez Chief Accounting Officer | Nov 10, 2025 | Option exercise | +31 | – | – | 949 |
| Chris Vazquez Chief Accounting Officer | Nov 10, 2025 | Sale | −13 | $7.62 | $99 | 936 |
| Robin Harper Cowie CFO, Sec'y & Treasurer | Nov 10, 2025 | Sale | −50 | $7.62 | $381 | 13,147 |
| Robin Harper Cowie CFO, Sec'y & Treasurer | Nov 10, 2025 | Option exercise | +158 | – | – | 13,197 |
| Gary Anthony Pestano Chief Development Officer | Nov 10, 2025 | Option exercise | +69 | – | – | 7,962 |
| Gary Anthony Pestano Chief Development Officer | Nov 10, 2025 | Sale | −23 | $7.62 | $175 | 7,939 |
| John Patience Director | Sep 30, 2025 | Option exercise | +1,144 | – | – | 21,518 |
| Jack W. Schuler Director, 10% owner | Sep 19, 2025 | Buy | +142,045 | $7.04 | $1,000.00K | 1,380,745 |
| Jack W. Schuler Director, 10% owner | Sep 18, 2025 | Buy | +3,056 | $6.17 | $18.86K | 1,238,700 |
| Jack W. Schuler Director, 10% owner | Sep 17, 2025 | Buy | +15,317 | $6.04 | $92.51K | 1,235,644 |
| Jack W. Schuler Director, 10% owner | Aug 29, 2025 | Buy | +3,488,372 | $0.43 | $1.50M | 24,406,546 |
| Chris Vazquez Chief Accounting Officer | Aug 13, 2025 | Sale | −228 | $0.42 | $96 | 18,375 |
| Kieran O'Kane Chief Commercial Officer | Aug 13, 2025 | Sale | −476 | $0.42 | $200 | 140,065 |
| Scott Hutton President & CEO, Director | Aug 13, 2025 | Sale | −3,772 | $0.42 | $1.58K | 728,824 |
| Gary Anthony Pestano Chief Development Officer | Aug 13, 2025 | Sale | −442 | $0.42 | $186 | 157,878 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Short % of shares outstanding
1.99%
0M shares short
Days to cover
2.5
At 0M shares a day
Change since last report
+0.2%
From 0M shares
Short volume, 20 days
51.9%
Of volume reported to FINRA
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Biodesix's stock actually held short. Settlement fails (shares not delivered on time) peaked at 110,520 shares on Aug 24, 2026 over the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Scott Hutton Officer, Director | Feb 23, 2026 | 1,490 | $19.03K | Feb 23, 2026 | Settlement of vested RSUs issued under an S-8 Registered Plan |
| Kieran O'Kane Officer | Feb 11, 2025 | 17,527 | $16.65K | Feb 11, 2025 | Settlement of vested RSUs issued under an S-8 Registered Plan |
| Scott Hutton Officer, Director | Feb 11, 2025 | 83,660 | $79.48K | Feb 11, 2025 | Settlement of vested RSUs issued under an S-8 Registered Plan |
| Gary Anthony Pestano Officer | Feb 11, 2025 | 16,748 | $15.91K | Feb 11, 2025 | Settlement of vested RSUs issued under an S-8 Registered Plan |
| Robin Harper Cowie Officer | Feb 11, 2025 | 24,664 | $23.43K | Feb 11, 2025 | Settlement of vested RSUs issued under an S-8 Registered Plan |
| Kieran O'Kane Officer | May 9, 2024 | 468 | $725 | May 9, 2024 | Settlement of vested RSUs issued under an S-8 Registered Plan |
| Robin Harper Cowie Officer | May 9, 2024 | 980 | $1.52K | May 9, 2024 | Settlement of vested RSUs issued under an S-8 Registered Plan |
| Gary Anthony Pestano Officer | May 9, 2024 | 434 | $673 | May 9, 2024 | Settlement of vested RSUs issued under an S-8 Registered Plan |
| Scott Hutton Officer, Director | May 9, 2024 | 3,764 | $5.83K | May 9, 2024 | Settlement of vested RSUs issued under an S-8 Registered Plan |
| Robin Harper Cowie Officer | Feb 9, 2024 | 18,855 | $37.52K | Feb 9, 2024 | Settlement of vested RSUs issued under an S-8 Registered Plan |
| Kieran O'Kane Officer | Feb 9, 2024 | 11,731 | $23.34K | Feb 9, 2024 | Settlement of vested RSUs issued under an S-8 Registered Plan |
| Gary Anthony Pestano Officer | Feb 9, 2024 | 10,884 | $21.66K | Feb 9, 2024 | Settlement of vested RSUs issued under an S-8 Registered Plan |
| Scott Hutton Officer, Director | Feb 9, 2024 | 64,390 | $128.14K | Feb 9, 2024 | Settlement of vested RSUs issued under an S-8 Registered Plan |
| Scott Hutton Officer, Director | Aug 9, 2023 | 13,782 | $22.05K | Aug 9, 2023 | Settlement of vested RSUs issued under an S-8 Registered Plan |
| Scott Hutton Section 16 Officer and Director | May 9, 2023 | 13,782 | $22.33K | May 9, 2023 | Settlement of vested RSUs issued under an S-8 Registered Plan |
See a number that looks wrong?